Success Metrics

Clinical Success Rate
72.7%

Based on 24 completed trials

Completion Rate
73%(24/33)
Active Trials
8(15%)
Results Posted
46%(11 trials)
Terminated
9(17%)

Phase Distribution

Ph phase_3
10
19%
Ph phase_2
9
17%
Ph phase_4
14
27%
Ph phase_1
5
10%
Ph not_applicable
5
10%

Phase Distribution

5

Early Stage

9

Mid Stage

24

Late Stage

Phase Distribution43 total trials
Phase 1Safety & dosage
5(11.6%)
Phase 2Efficacy & side effects
9(20.9%)
Phase 3Large-scale testing
10(23.3%)
Phase 4Post-market surveillance
14(32.6%)
N/ANon-phased studies
5(11.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

24 of 36 finished

Non-Completion Rate

33.3%

12 ended early

Currently Active

8

trials recruiting

Total Trials

52

all time

Status Distribution
Active(9)
Completed(24)
Terminated(12)
Other(7)

Detailed Status

Completed24
Terminated9
Recruiting7
unknown6
Withdrawn3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
52
Active
8
Success Rate
72.7%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (11.6%)
Phase 29 (20.9%)
Phase 310 (23.3%)
Phase 414 (32.6%)
N/A5 (11.6%)

Trials by Status

unknown612%
completed2446%
not_yet_recruiting12%
recruiting713%
suspended12%
terminated917%
active_not_recruiting12%
withdrawn36%

Recent Activity

Clinical Trials (52)

Showing 20 of 52 trialsScroll for more
NCT06712641Phase 4

Aminoglycosides in Early Sepsis

Recruiting
NCT03078010Phase 2

Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant

Active Not Recruiting
NCT06954129Phase 4

A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients

Recruiting
NCT06426836Not Applicable

Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

Recruiting
NCT03269994Phase 3

Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

Completed
NCT03671967Phase 4

PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)

Recruiting
NCT06184659Phase 4

Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis

Recruiting
NCT06977347Not Applicable

Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea

Not Yet Recruiting
NCT02820987Phase 3

PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock

Completed
NCT04983901Phase 2

PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN

Completed
NCT05753735Phase 2

eXtended Antibiotic Prophylaxis for Intermediate- and High-risk Glands After Pancreatoduodenectomy to Reduce CR-POPF

Terminated
NCT04276480Not Applicable

Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers.

Completed
NCT02735707Phase 3

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Recruiting
NCT06422533Not Applicable

Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients

Recruiting
NCT05981079Phase 4

Model-based Dose Versus Empirical Dose of Piperacillin/Tazobactam in Preterm Neonates With Late-onset Sepsis.

Unknown
NCT05943223Phase 2

Piperacillin/Tazobactam Versus ceftriAxone and Metronidazole for Children With Perforated Appendicitis (ALPACA)

Unknown
NCT03262142Phase 4

Targeted AntiBiotics for Chronic Pulmonary Diseases

Terminated
NCT04394182Not Applicable

Ultra Low Doses of Therapy With Radiation Applicated to COVID-19

Suspended
NCT03922451

Pharmacokinetics of Antibiotics During Extracorporeal Membrane Oxygenation (ECMO) Support

Terminated
NCT03485950Phase 2

Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam

Completed

Drug Details

Intervention Type
DRUG
Total Trials
52